Current and historical daily PE Ratio for DreamCIS INC (
XKRX:223250
) from 2020 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. DreamCIS stock (XKRX:223250) PE ratio as of Jun 21 2024 is 21.66.
More Details
DreamCIS INC (XKRX:223250) PE Ratio (TTM) Chart
DreamCIS INC (XKRX:223250) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 1055
- 1
- 2
- 3
- 4
- 5
- 6
- 12
DreamCIS PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-22 | 21.6 | 2024-04-16 | 17.2 |
2024-06-21 | 21.6 | 2024-04-15 | 18.2 |
2024-06-20 | 21.6 | 2024-04-12 | 18.7 |
2024-06-19 | 21.1 | 2024-04-11 | 18.6 |
2024-06-18 | 20.8 | 2024-04-09 | 18.6 |
2024-06-17 | 21.3 | 2024-04-08 | 18.4 |
2024-06-14 | 21.2 | 2024-04-05 | 18.7 |
2024-06-13 | 21.9 | 2024-04-04 | 18.8 |
2024-06-12 | 22.8 | 2024-04-03 | 18.8 |
2024-06-11 | 21.3 | 2024-04-02 | 19.3 |
2024-06-10 | 21.4 | 2024-04-01 | 19.9 |
2024-06-07 | 21.1 | 2024-03-29 | 19.3 |
2024-06-05 | 21.1 | 2024-03-28 | 19.8 |
2024-06-04 | 21.2 | 2024-03-27 | 21.2 |
2024-06-03 | 21.5 | 2024-03-26 | 21.7 |
2024-05-31 | 21.1 | 2024-03-25 | 21.6 |
2024-05-30 | 21.1 | 2024-03-22 | 21.1 |
2024-05-29 | 21.8 | 2024-03-21 | 20.6 |
2024-05-28 | 21.5 | 2024-03-20 | 20.3 |
2024-05-27 | 21.6 | 2024-03-19 | 20.1 |
2024-05-24 | 21.6 | 2024-03-18 | 20.8 |
2024-05-23 | 22.2 | 2024-03-15 | 20.1 |
2024-05-22 | 22.8 | 2024-03-14 | 20.3 |
2024-05-21 | 23.3 | 2024-03-13 | 20.6 |
2024-05-20 | 23.8 | 2024-03-12 | 20.7 |
2024-05-17 | 23.8 | 2024-03-11 | 21.2 |
2024-05-16 | 25.4 | 2024-03-08 | 21.4 |
2024-05-14 | 27.5 | 2024-03-07 | 20.7 |
2024-05-13 | 27.3 | 2024-03-06 | 21.0 |
2024-05-10 | 27.3 | 2024-03-05 | 20.7 |
2024-05-09 | 27.2 | 2024-03-04 | 20.4 |
2024-05-08 | 24.9 | 2024-02-29 | 20.0 |
2024-05-07 | 25.9 | 2024-02-28 | 20.1 |
2024-05-03 | 24.9 | 2024-02-27 | 20.4 |
2024-05-02 | 19.4 | 2024-02-26 | 20.6 |
2024-04-30 | 19.4 | 2024-02-23 | 20.6 |
2024-04-29 | 19.2 | 2024-02-22 | 20.8 |
2024-04-26 | 19.2 | 2024-02-21 | 21.0 |
2024-04-25 | 19.0 | 2024-02-20 | 21.2 |
2024-04-24 | 17.9 | 2024-02-19 | 21.3 |
2024-04-23 | 17.5 | 2024-02-16 | 21.3 |
2024-04-22 | 17.6 | 2024-02-15 | 21.1 |
2024-04-19 | 17.3 | 2024-02-14 | 21.1 |
2024-04-18 | 17.6 | 2024-02-13 | 21.1 |
2024-04-17 | 17.3 | 2024-02-08 | 20.5 |
DreamCIS INC (XKRX:223250) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
DreamCIS INC
ISIN : KR7223250002
Share Class Description:
XKRX:223250: Ordinary SharesCompare
Compare
Traded in other countries / regions
223250.Korea IPO Date
2020-05-22Description
DreamCIS INC operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.